Name | tert-butyl 5-methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzimidazole-1-carboxylate |
---|---|
Synonyms |
5-methyl-6-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzoimidazole-1-carboxylic acid tert-butyl ester
1-Boc-5-methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzimidazole tert-Butyl 5-methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]imidazole-1-carboxylate |
Molecular Formula | C19H27BN2O4 |
---|---|
Molecular Weight | 358.24000 |
Exact Mass | 358.20600 |
PSA | 62.58000 |
LogP | 3.42710 |
HS Code | 2934999090 |
---|
~% 631909-46-1
Detail
|
Literature: 3-DIMENSIONAL PHARMACEUTICALS, INC. Patent: WO2003/99805 A1, 2003 ; Location in patent: Page 123 ; |
~50% 631909-46-1 |
Literature: 3-Dimensional Pharmaceuticals, Inc. Patent: US2004/9995 A1, 2004 ; |
Precursor 4 | |
---|---|
DownStream 0 |
HS Code | 2934999090 |
---|---|
Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |